Tammy Cameron

Intuity Medical, Inc. develops a blood glucose monitoring system for diabetic patients. The firm offers POGO Automatic, an automated, self-contained handheld monitor that enables patients to measure blood glucose levels within seconds. It also offer Patterns, an application which centralizes each patient?s blood glucose testing data in a digital form that can be shared with healthcare providers. The company was founded by Syrous Parsay on April 24, 2002 and is headquartered in Fremont, CA.

Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA.

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Cytyc Prenatal Products Corp. provides products for the diagnosis of pregnancy related and female reproductive disorders. The company also designs, develops, and manufactures women health care products. It was founded in 1985 and is headquartered in Sunnyvale, CA

Part of PTC, Inc., Rasna Corp. is a prepackaged software company. The company is based in San Jose, CA. The company was founded by Dave W. Pidwell. Rasna was acquired by PTC, Inc. on August 02, 1995 for $231.30 million.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision.